Literature DB >> 17823107

Stability of oxaliplatin in infusion bags containing 5% dextrose injection.

Pascal André1, Salvatore Cisternino, Anne-Lise Roy, Fouad Chiadmi, Joël Schlatter, Pascal Agranat, Olivier Fain, Jean-Eudes Fontan.   

Abstract

PURPOSE: The stability of oxaliplatin in infusion bags containing 5% dextrose injection was studied.
METHODS: Solutions of oxaliplatin 0.7 mg/mL were prepared in polyolefin infusion bags containing 5% dextrose injection and stored at 3-7 degrees C in a lightproof bag, at 20-24 degrees C with continuous exposure to artificial light, and at 20-24 degrees C with continuous exposure to fluorescent light in a lightproof bag. Samples were analyzed at 1, 2, 3, 4, 5, 7, 14, and 30 days and assayed in duplicate. Stability was measured using a stability-indicating high-performance liquid chromatographic method. Samples were also examined for changes in color and pH and for the presence of particulate matter.
RESULTS: All samples retained over 90% of their initial concentration over the study period. No color changes or visible precipitation was observed, and the pH of all samples remained stable. Neither temperature nor artificial light had any significant effect on the stability of oxaliplatin.
CONCLUSION: Oxaliplatin 0.7 mg/mL in infusion bags containing 5% dextrose injection was chemically stable for at least 30 days at both 3-7 degrees C and 20-24 degrees C without regard to light exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823107     DOI: 10.2146/ajhp060369

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  3 in total

Review 1.  Stability of antineoplastic agents in use for home-based intravenous chemotherapy.

Authors:  Frédéric Benizri; Brigitte Bonan; Anne-Laure Ferrio; Marie-Laure Brandely; Vincent Castagné; Nathalie Théou-Anton; Muriel Verlinde-Carvalho; Laurent Havard
Journal:  Pharm World Sci       Date:  2008-12-10

2.  Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study.

Authors:  Olivia Sgarbura; Emmanuelle Samalin; Sébastien Carrere; Thibault Mazard; Hélène de Forges; Mathias Alline; Marie-Hélène Pissas; Fabienne Portales; Marc Ychou; François Quenet
Journal:  Pleura Peritoneum       Date:  2016-12-21

Review 3.  Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application.

Authors:  Girolamo Ranieri; Mariarita Laforgia; Patrizia Nardulli; Simona Ferraiuolo; Pasquale Molinari; Ilaria Marech; Cosmo Damiano Gadaleta
Journal:  Cancers (Basel)       Date:  2019-01-24       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.